BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

Evolutec Finds Better Reception, Raises £9.5M In Private Round

March 30, 2005
By Nuala Moran
LONDON - Evolutec Group plc raised £9.5 million (US$17.7 million) in a secondary fund raising that was more than two times oversubscribed, just seven months after its initial public offering was pegged back from a hoped-for £7.5 million to £5.1 million. (BioWorld International)
Read More

Prospects For GM Crops In UK Not Encouraging Following Trial

March 30, 2005
By Nuala Moran

Oxford Genome Establishes Biomarker Deal With Bayer

March 23, 2005
By Nuala Moran

Plethora Makes Comeback With £10M Flotation On AIM

March 23, 2005
By Nuala Moran
LONDON - Plethora Solutions Holdings, a specialist in sexual dysfunction and urology products, raised £10 million (US$19 million) in a flotation on the Alternative Investment Market in London. (BioWorld International)
Read More

Oxford Genome Establishes Biomarker Deal With Bayer

March 23, 2005
By Nuala Moran

Plethora Makes Comeback With £10M Flotation On AIM

March 23, 2005
By Nuala Moran
LONDON - Plethora Solutions Holdings, a specialist in sexual dysfunction and urology products, raised £10 million (US$19 million) in a flotation on the Alternative Investment Market in London. (BioWorld International)
Read More

Benefiting From Government Work, Acambis Plans Ahead

March 16, 2005
By Nuala Moran

Proximagen Filing For £12M Initial Public Offering On AIM

March 16, 2005
By Nuala Moran

Benefiting From Government Work, Acambis Plans Ahead

March 16, 2005
By Nuala Moran

Proximagen Filing For £12M Initial Public Offering On AIM

March 16, 2005
By Nuala Moran
View All Articles by Nuala Moran

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 6, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • Brain illustrated with pills

    Serotonin receptor modulators for the treatment of OUD

    BioWorld Science
    Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
  • Liver anatomy illustration

    KLF15 shows potential as marker, target for cholangiocarcinoma

    BioWorld Science
    Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing